Cha Bio Group|차바이오그룹

Cha Bio Group|차바이오그룹 company information, Employees & Contact Information

차바이오그룹은 바이오∙헬스케어 산업에서 최초을 넘어 최고를 향한 도전을 이어가고 있습니다. 국내 유일의 산∙학∙연∙병(産∙學∙硏∙病) 에코시스템과 세계 최대 셀라이브러리, 면역증강플랫폼 등 차별화된 R&D 역량으로 세포∙유전자치료제, 차세대 백신, 표적항암제 등 첨단 바이오의약품을 개발하고 있습니다. 차바이오그룹은 차바이오텍, CMG제약, 차백신연구소 3개의 상장기업과 차헬스케어, 차메디텍, 차바이오F&C, 차케어스, 서울CRO, 솔리더스인베스트먼트 등의 기업들이 수직 계열화를 통해 비즈니스를 극대화하고 있습니다. 차바이오그룹의 도전과 혁신은 계속됩니다. 미국 마티카 바이오테크놀로지를 통해 3세대 CGT CDMO 사업을 본격화하고 있으며, LA 할리우드 차병원을 시작으로 미국, 호주, 일본, 동남아시아에 직접 진출해 메디컬 한류를 선도하고 있습니다. CHA Bio Group is continuing its challenge to become the best in various initial achievements in the bio and healthcare fields. We are developing and producing advanced biopharmaceuticals, including cell and gene therapy products and vaccines, based on our global R&D capabilities, such as our unique ‘CHA Bio ecosystem’: Academic, Research, Medical Network, and Bio-Industry Business, the world's largest cell library, and our independently developed vaccine adjuvant platform. We will leap forward as a true global bio company centered on the third-generation CGT CDMO and global healthcare business.

Company Details

Employees
55
Address
335, Pangyo-Ro, Cha Bio Complex,korea, Republic Of
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Bundang-gu, Seongnam-si, Gyeonggi-do
Looking for a particular Cha Bio Group|차바이오그룹 employee's phone or email?

Cha Bio Group|차바이오그룹 Questions

News

Cha Won-tae named vice chairman of CHA Bio Group and CSO of CHA Biotech - koreabiomed.com

Cha Won-tae named vice chairman of CHA Bio Group and CSO of CHA Biotech koreabiomed.com

Fous on Research: CHA Bio to Establish Global Open Innovation Center - Businesskorea

Fous on Research: CHA Bio to Establish Global Open Innovation Center Businesskorea

Cha Bio Group unveils Pangyo cell and gene therapy hub plan - CHOSUNBIZ - Chosun Biz

Cha Bio Group unveils Pangyo cell and gene therapy hub plan - CHOSUNBIZ Chosun Biz

CHA Bio F&C, Cosmecca team up to co-develop stem cell-powered skincare ingredients - koreabiomed.com

CHA Bio F&C, Cosmecca team up to co-develop stem cell-powered skincare ingredients koreabiomed.com

EVERCELL, a premium anti-aging cosmetics brand of ChaBio F&C (CEO Kim Seok-jin), a subsidiary of.. - 매일경제

EVERCELL, a premium anti-aging cosmetics brand of ChaBio F&C (CEO Kim Seok-jin), a subsidiary of.. 매일경제

CHA Bio Group to display cell, gene therapy abilities at BIO USA - Korea JoongAng Daily

CHA Bio Group to display cell, gene therapy abilities at BIO USA Korea JoongAng Daily

Korea's Cha Bio Group to expand overseas real estate business - The Korea Economic Daily Global Edition

Korea's Cha Bio Group to expand overseas real estate business The Korea Economic Daily Global Edition

Cha Bio Group Advances Stem Cell Culture Fluid Cosmetics with New Protein Findings - Businesskorea

Cha Bio Group Advances Stem Cell Culture Fluid Cosmetics with New Protein Findings Businesskorea

CHA Bio, Cambridge Innovation Center to establish cell and gene therapy center in Pangyo - The Korea Times

CHA Bio, Cambridge Innovation Center to establish cell and gene therapy center in Pangyo The Korea Times

Sorrento to Form Joint Venture with CHA Biotech to Develop and Commercialize Natural Killer Cell Therapies - PR Newswire

Sorrento to Form Joint Venture with CHA Biotech to Develop and Commercialize Natural Killer Cell Therapies PR Newswire

CHA Bio breaks ground on new cell and gene facility - Korea JoongAng Daily

CHA Bio breaks ground on new cell and gene facility Korea JoongAng Daily

IGIS Asia Investment Management Partners with CHA Bio Group to Launch Life Science Real Estate Platform JV - Media OutReach Newswire

IGIS Asia Investment Management Partners with CHA Bio Group to Launch Life Science Real Estate Platform JV Media OutReach Newswire

CHA Bio Group to showcase cell and gene tech at BIO 2024 in US - koreabiomed.com

CHA Bio Group to showcase cell and gene tech at BIO 2024 in US koreabiomed.com

Cha Biotech announced on the 31st that it has hired Nam Soo-yeon, former president of GI Innovation - 매일경제

Cha Biotech announced on the 31st that it has hired Nam Soo-yeon, former president of GI Innovation 매일경제

CHA Bio Group, GenKOre team up to tackle rare blood disease with gene therapy - koreabiomed.com

CHA Bio Group, GenKOre team up to tackle rare blood disease with gene therapy koreabiomed.com

Top Cha Bio Group|차바이오그룹 Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant